Need Help?
Sign In
(888) 354-2873
Schedule Call
Live Chat
Email Us
Get Spark
Cures Pro
Centers
Trials
Sign In
Need Help?
(888) 354-2873
Schedule Call
Live Chat
Email Us
Get Spark
Cures Pro
Home
Centers
Trials
Screener
Create Account
Massachusetts General Hospital
Boston, MA
Filters
Save & Share
Clear Filters
Show All Filters
Diagnosis
Multiple Myeloma
Smoldering "Asymptomatic" Multiple Myeloma
Monoclonal Gammopathy of Undetermined Significance (MGUS)
Treatment History
Select
Untreated
First Line
Relapsed/Refractory
Prior BCMA Therapy
Select
I've had prior BCMA therapy
No prior BCMA therapy
This stands for B Cell Maturation Antigen (BCMA) and includes treatments such as ide-cel, cilta-cel or belantamab mafodotin.
Help Me Find Trials
Sorting
1
by
Sort by
Relevancy
Accepting patients
QUINTESSENTIAL
Phase 2 Study of BMS-986393, a GPRC5D-directed CART-Cell Therapy, in Participants with Relapsed or Refractory Multiple Myeloma
Learn more
CAR T Cell
GPRC5D
Phase 2
Showing
1-1
of
1